NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12/04/2024
Voltar para busca
Dado oficial do USPTO
LYMPHOTRACK
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
63
Atualização mais recente
12/04/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5
Data de depósito
04/06/2010
Data de registro
08/04/2014
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
12/04/2024
Última transação
12/04/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
18/11/2005
Primeiro uso no comércio
10/04/2006
Código do desenho
4
Tipo de titular
03
Localização do titular
SAN DIEGO, CA, US
Examinador
ORTIGA PALMER, RAMONA
Unidade examinadora
M80
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
INVIVOSCRIBE, INC.
Invivoscribe Technologies, Inc.
Representantes
Sarah W. Matthews Dentons Durham Jones Pinegar
Classificação técnica
Classes Nice
Classe 1Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Reagents for scientific and research usebuffer solutionsenzymesmolecular probesDNA and RNA polymerasesnucleic acidsnucleic acid derivativesprimers for use in PCRDNA templatesRNA templatesdyes and biotechnology reagents and solvents for sample preparationpurificationlysismodification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of buffer solutionsenzymesmolecular probesDNA and RNA polymerasesnucleic acidsnucleic acid derivativesprimers for use in PCRDNA templatesRNA templatesdyes and biotechnology reagents and solvents for sample preparationpurificationlysismodification and manipulation of cells; diagnostic reagent kits for scientific and research use comprised of chemical and biological reagents for non-medical purposes; diagnostic reagents for scientific and research use; diagnostic assays for researchclinical or medical laboratory use
Classe 5
Assays for the treatment or diagnosis of disease; medical diagnostic reagentsbuffer solutionsenzymesmolecular probesDNA and RNA polymerasesnucleic acidsnucleic acid derivativesprimers for use in PCRDNA templatesRNA templatesdyes and biotechnology reagents and solvents for sample preparationpurificationlysismodification and manipulation of cells; medical diagnostic kits comprised of buffer solutionsenzymesmolecular probesDNA and RNA polymerasesnucleic acidsnucleic acid derivativesprimers for use in PCRDNA templatesRNA templatesdyes and biotechnology reagents and solvents for sample preparationpurificationlysismodification and manipulation of cells; medical diagnostic reagent kits comprised of chemical and biological reagents for the treatmentmonitoring and diagnosis of disease; medical diagnostic reagent kits comprised of medical reagents for clinical or medical use; medical diagnostic assays for the treatment and diagnosis of disease; medical diagnostic assays for researchclinical and medical use
Publicações
Histórico de despachos e eventos da marca no USPTO.
63 publicações encontradas
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
12/04/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/04/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/04/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
01/12/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/04/2023
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
30/09/2020
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
30/09/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
30/09/2020
E815
TEAS SECTION 8 & 15 RECEIVED
24/09/2020
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/04/2019
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
05/09/2018
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
28/03/2018
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
28/03/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
08/04/2014
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/03/2014
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
05/03/2014
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
25/02/2014
SUPC
STATEMENT OF USE PROCESSING COMPLETE
25/02/2014
IUAF
USE AMENDMENT FILED
30/01/2014
EISU
TEAS STATEMENT OF USE RECEIVED
30/01/2014
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/08/2013
EX3G
SOU EXTENSION 3 GRANTED
06/08/2013
EXT3
SOU EXTENSION 3 FILED
30/07/2013
EEXT
SOU TEAS EXTENSION RECEIVED
30/07/2013
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
27/02/2013
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
27/02/2013
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/02/2013
EX2G
SOU EXTENSION 2 GRANTED
11/02/2013
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/02/2013
EXT2
SOU EXTENSION 2 FILED
30/01/2013
EEXT
SOU TEAS EXTENSION RECEIVED
30/01/2013
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/08/2012
EX1G
SOU EXTENSION 1 GRANTED
30/07/2012
EXT1
SOU EXTENSION 1 FILED
30/07/2012
EEXT
SOU TEAS EXTENSION RECEIVED
30/07/2012
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
31/01/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/12/2011
PUBO
PUBLISHED FOR OPPOSITION
06/12/2011
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
16/11/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/11/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
25/10/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/10/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/09/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
30/09/2011
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
18/05/2011
GNRT
NON-FINAL ACTION E-MAILED
18/05/2011
CNRT
NON-FINAL ACTION WRITTEN
18/05/2011
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
06/05/2011
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
22/04/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/04/2011
ALIE
ASSIGNED TO LIE
09/04/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
29/03/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/03/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/03/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/03/2011
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/09/2010
GNRT
NON-FINAL ACTION E-MAILED
08/09/2010
CNRT
NON-FINAL ACTION WRITTEN
08/09/2010
DOCK
ASSIGNED TO EXAMINER
26/08/2010
MPMK
NOTICE OF PSEUDO MARK MAILED
10/06/2010
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/06/2010
NWAP
NEW APPLICATION ENTERED
08/06/2010
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LYMPHOTRACK ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.